Changchun shengboma biomaterials co., Ltd. was established in 2007 months. main carried out bio can degradation medical with polymer material of production and the downstream products of development and industrialization, as: L-c cross ester (L-LA), and d-c cross ester (D-LA), and DL-c cross ester (DL-LA), and b cross ester (GA), poly L-c cross ester (PLLA), and Poly D-c cross ester (PDLA), and poly DL-c cross ester (PDLLA), and poly (L-c cross ester-b cross ester) (PLGA), and poly (DL-c cross ester-b cross ester) (PDLGA), and Methoxy peg-poly-l-lactide (mPEG-PLA), methoxy peg-poly-DL-c ester (mPEG-PDLLA), poly esters (PGA), poly-e-caprolactone (PCL) and their copolymers; bone nail and absorbable bone fracture internal fixation device and bone tissue engineering scaffolds, drug delivery materials.

the total investment $ 33.55 million, covering an area of 10,000 square meters, it has 3,500 square metres of comprehensive experimental building GMP and 3,500 square meters standard workshop. the existing college education staff accounted for more than 90%. key management personnel abroad for many years, profound academic credentials, rich management experience; technician professional background covering areas such as chemistry, biology, medicine, with strong product innovation and research and development.

Changchun Institute of applied chemistry, Chinese Academy of Sciences as a technical support unit, Jilin province in 2007 and 2009 respectively joint poly lactic acid biodegradable material polylactic acid medical technology innovation Center and Changchun City Science Innovation Center. two Centre actively promotes the development of polylactic acid industry and application of polylactic acid on the medical technology research and product development, realize the integration of production, learning and research goals.